NGHLF (Nightingale Health) 3-Year RORE % : 4.57% (As of Dec. 2025)


NGHLF Nightingale Health PLC NGHLF
50 GF Score
Price $1.19
GF Value $2.67
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Nightingale Health 3-Year RORE %?

Nightingale Health NGHLF 50 3-Year RORE % is 4.57 as of Dec. 2025. GuruFocus rates NGHLF with a GF Score™ of 50/100 and a GF Value™ of $2.67 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 606 Healthcare Providers & Services companies, Nightingale Health ranks better than 51.65% on this metric.

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Nightingale Health's 3-Year RORE % for the quarter that ended in Dec. 2025 was 4.57%.

The industry rank for Nightingale Health's 3-Year RORE % or its related term are showing as below:

NGHLF's 3-Year RORE % is ranked better than
51.65% of 606 companies
in the Healthcare Providers & Services industry
Industry Median: 0.195 vs NGHLF: 4.57

Nightingale Health  (OTCPK:NGHLF) 3-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


Nightingale Health 3-Year RORE % Related Terms


Nightingale Health 3-Year RORE % Historical Data

* Premium members only.

The historical data trend for Nightingale Health's 3-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nightingale Health 3-Year RORE % Chart

Nightingale Health Annual Data
Trend Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
3-Year RORE %
Get a 7-Day Free Trial 0.00 28.87 10.83 2.71 2.25

Nightingale Health Semi-Annual Data
Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
3-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.24 2.71 -2.18 2.25 4.57

NGHLF vs VEEV, BTSG, TEM: 3-Year RORE % Comparison

For the Health Information Services subindustry, Nightingale Health's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nightingale Health 3-Year RORE % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Nightingale Health's 3-Year RORE % distribution charts can be found below:

* The bar in red indicates where Nightingale Health's 3-Year RORE % falls into.


NGHLF
50GF Score
Nightingale Health PLC NGHLF
3-Year RORE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nightingale Health 3-Year RORE % Calculation

Nightingale Health's 3-Year RORE % for the quarter that ended in Dec. 2025 is calculated as:

3-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 3-year -Cumulative Dividends per Share for 3-year )
=( -0.372--0.326 )/( -1.006-0 )
=-0.046/-1.006
=4.57 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Dec. 2025 and 3-year before.

Frequently Asked Questions Learn more about 3-Year RORE % →
What does a 3-Year RORE % of 4.57 mean?
Nightingale Health (NGHLF) has a 3-Year RORE % of 4.57 as of Dec. 2025. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Nightingale Health and its competitors. According to the industry distribution chart, Nightingale Health ranks #293 out of 606 companies in the Healthcare Providers & Services industry, placing it in the top 48.3%.
Is Nightingale Health's 3-Year RORE % too high?
Nightingale Health's current 3-Year RORE % is 4.57. The Healthcare Providers & Services industry median 3-Year RORE % is 0.20. Nightingale Health's value of 4.57 is 2243.6% above this industry median. Based on the distribution chart, Nightingale Health ranks #293 out of 606 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Nightingale Health has a GF Score™ of 50/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Nightingale Health's 3-Year RORE % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Nightingale Health ranks #293 out of 606 companies for 3-Year RORE %. This puts Nightingale Health in the upper half of its industry. The industry median 3-Year RORE % is 0.20. Nightingale Health's value of 4.57 is 2243.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Healthcare Providers & Services company?
The median 3-Year RORE % among Healthcare Providers & Services companies is 0.20, based on 606 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year RORE % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nightingale Health's current 3-Year RORE % of 4.57 is 2243.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Nightingale Health and its competitors. For the Healthcare Providers & Services industry, the median 3-Year RORE % is 0.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nightingale Health's current 3-Year RORE % is 4.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nightingale Health stock overvalued right now?
Based on GuruFocus' analysis, Nightingale Health (NGHLF) is currently considered Possible Value Trap. The stock's GF Value™ is $2.67, compared to a current price of $1.19 — trading 55.4% below its estimated fair value. The current 3-Year RORE % is 4.57 and 2243.6% above the Healthcare Providers & Services industry median of 0.20. Nightingale Health's overall GF Score™ is 50/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For Nightingale Health (NGHLF), the current 3-Year RORE % is 4.57 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nightingale Health (NGHLF) Overvalued in 2026?

Based on GuruFocus' analysis, Nightingale Health stock appears to be undervalued. The current stock price of $1.19 is trading 55.4% below its estimated GF Value™ of $2.67. GuruFocus considers Nightingale Health to be Possible Value Trap.

Key valuation signals for NGHLF:

  • 3-Year RORE %: 4.57
  • GF Value™: $2.67 vs. price of $1.19 (55.4% below fair value)
  • GF Score™: 50/100 with 6 warning signs
  • Industry Position: 2243.6% above the Healthcare Providers & Services median (#293 of 606)

No single metric tells the full story. See the NGHLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Nightingale Health Business Description

Other Exchanges HEALTH:Finland7XE:Germany
Address Mannerheimintie 164a, Helsinki, FIN, 00300
Nightingale Health PLC offers a health data platform that detects disease risks. The Health Data Platform empowers individuals to take actions to prevent diseases by allowing them access to disease risk information. With its Health Data Platform, the company connects the services of healthcare actors with the preventative health needs of individuals. The company operates in Finland, Japan, the United Kingdom, Singapore, and the USA.
50GF Score

Get the complete analysis for NGHLF

3-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.19
Price
$2.67
GF Value